FIRST MANHATTAN CO. LLC. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,620
-24.7%
4000.0%0.00%
Q2 2023$12,772
+4.3%
4000.0%0.00%
Q1 2023$12,248
-21.7%
4000.0%0.00%
Q4 2022$15,644
-17.7%
4000.0%0.00%
Q3 2022$19,000
+26.7%
4000.0%0.00%
Q2 2022$15,000
-31.8%
4000.0%0.00%
Q1 2022$22,000
-29.0%
4000.0%0.00%
Q4 2021$31,000
-8.8%
4000.0%0.00%
Q3 2021$34,000
-33.3%
4000.0%0.00%
Q2 2021$51,000
+59.4%
4000.0%0.00%
Q1 2021$32,0000.0%4000.0%0.00%
Q4 2020$32,000
+255.6%
4000.0%0.00%
Q3 2020$9,0004000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders